New product! EGFR Multiplex cfDNA Reference Standard Set

Please log in for more information

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the Retina field I want to stay up to date with the Infectious Diseases field I want to stay up to date with the Pathologist Educator field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

Contact Information:

8100 Beach Drive, Cambridge Research Park, Waterbeach, Cambridge CB25 9TL
Phone: 01223 976000
Email: [email protected]

Company website

Horizon is part of the Revvity, Inc. portfolio.

Previously shared content as well as information about Horizon’s solutions can be found by visiting Revvity’s supplier/profile page.

Horizon Discovery Group PLC is a world leader in the utilization of gene editing and gene modulation technologies to support the greater understanding of gene function, the genetic drivers behind human disease and the development of personalized molecular, cell and gene therapies.

The company’s products and services are used by thousands of scientists working in academic institutes, pharmaceutical companies and clinical diagnostic laboratories around the globe. Horizon is headquartered in Cambridge, UK.